Effect of Systemic Intraoperative Heparin Use on Upper Extremity Arteriovenous Fistula Patency in End-Stage Renal Disease Patients

The formation of the arteriovenous fistula is an important method of vascular access for patients with end-stage renal disease (ESRD). This allows renal filtration resulting in improved life quality and expectancy for ESRD patients. The biggest drawback to arteriovenous fistula formation is thrombos...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Morwan Bahi
Formato:	article
Lenguaje:	EN
Publicado:	Hindawi Limited 2021
Materias:	Technology T Medicine R Science Q
Acceso en línea:	https://doaj.org/article/60e4f1e82bda497dbb10b8b2440bd519
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:60e4f1e82bda497dbb10b8b2440bd519
record_format	dspace
spelling	oai:doaj.org-article:60e4f1e82bda497dbb10b8b2440bd5192021-11-08T02:36:48ZEffect of Systemic Intraoperative Heparin Use on Upper Extremity Arteriovenous Fistula Patency in End-Stage Renal Disease Patients1537-744X10.1155/2021/2965743https://doaj.org/article/60e4f1e82bda497dbb10b8b2440bd5192021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/2965743https://doaj.org/toc/1537-744XThe formation of the arteriovenous fistula is an important method of vascular access for patients with end-stage renal disease (ESRD). This allows renal filtration resulting in improved life quality and expectancy for ESRD patients. The biggest drawback to arteriovenous fistula formation is thrombosis, which can occur at an early or delayed stage. One suggested method of reducing postoperative arteriovenous fistula thrombosis rates is the administration of intraoperative systemic heparin. Heparin use in this context is debated, and there is currently no consensus on its use. There are a number of small randomised control studies trialling use of heparin but no large systematic trials. In this report, we collate existing evidence in the form of a review article and attempt to extrapolate a consensus of the evidence.Morwan BahiHindawi LimitedarticleTechnologyTMedicineRScienceQENThe Scientific World Journal, Vol 2021 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Technology T Medicine R Science Q
spellingShingle	Technology T Medicine R Science Q Morwan Bahi Effect of Systemic Intraoperative Heparin Use on Upper Extremity Arteriovenous Fistula Patency in End-Stage Renal Disease Patients
description	The formation of the arteriovenous fistula is an important method of vascular access for patients with end-stage renal disease (ESRD). This allows renal filtration resulting in improved life quality and expectancy for ESRD patients. The biggest drawback to arteriovenous fistula formation is thrombosis, which can occur at an early or delayed stage. One suggested method of reducing postoperative arteriovenous fistula thrombosis rates is the administration of intraoperative systemic heparin. Heparin use in this context is debated, and there is currently no consensus on its use. There are a number of small randomised control studies trialling use of heparin but no large systematic trials. In this report, we collate existing evidence in the form of a review article and attempt to extrapolate a consensus of the evidence.
format	article
author	Morwan Bahi
author_facet	Morwan Bahi
author_sort	Morwan Bahi
title	Effect of Systemic Intraoperative Heparin Use on Upper Extremity Arteriovenous Fistula Patency in End-Stage Renal Disease Patients
title_short	Effect of Systemic Intraoperative Heparin Use on Upper Extremity Arteriovenous Fistula Patency in End-Stage Renal Disease Patients
title_full	Effect of Systemic Intraoperative Heparin Use on Upper Extremity Arteriovenous Fistula Patency in End-Stage Renal Disease Patients
title_fullStr	Effect of Systemic Intraoperative Heparin Use on Upper Extremity Arteriovenous Fistula Patency in End-Stage Renal Disease Patients
title_full_unstemmed	Effect of Systemic Intraoperative Heparin Use on Upper Extremity Arteriovenous Fistula Patency in End-Stage Renal Disease Patients
title_sort	effect of systemic intraoperative heparin use on upper extremity arteriovenous fistula patency in end-stage renal disease patients
publisher	Hindawi Limited
publishDate	2021
url	https://doaj.org/article/60e4f1e82bda497dbb10b8b2440bd519
work_keys_str_mv	AT morwanbahi effectofsystemicintraoperativeheparinuseonupperextremityarteriovenousfistulapatencyinendstagerenaldiseasepatients
_version_	1718443098806157312

Effect of Systemic Intraoperative Heparin Use on Upper Extremity Arteriovenous Fistula Patency in End-Stage Renal Disease Patients

Ejemplares similares